DataVXJournal of Biomedical Materials Research Part B: Applied BiomaterialsPaper
journal article·2018-01

Osteogenic potential of stem cells‐seeded bioactive nanocomposite scaffolds: A comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue

Saeid Kargozar, Masoud Mozafari, Seyed Jafar Hashemian, Peiman Brouki Milan, Sepideh Hamzehlou, Mansooreh Soleimani, Mohammad Taghi Joghataei, Mazaher Gholipourmalekabadi, Alireza Korourian, Kazem Mousavizadeh, Alexander M. Seifalian

Journal of Biomedical Materials Research Part B: Applied Biomaterials· Volume 106· Issue 1
Publisher page
Source abstract

Abstract

Abstract Bone regeneration is considered as an unmet clinical need, the aim of this study is to investigate the osteogenic potential of three different mesenchymal stem cells (MSCs) derived from human bone marrow (BM‐MSCs), umbilical cord Wharton's jelly (UC‐MSCs), and adipose (AD‐MSCs) seeded on a recently developed nanocomposite scaffold (bioactive glass/gelatin) implanted in rat animal models with critical size calvarial defects. In this study, after isolation, culture, and characterization, the MSCs were expanded and seeded on the scaffolds for in vitro and in vivo studies. The adhesion, proliferation, and viability of the cells on the scaffolds evaluated in vitro, showed that the scaffolds were biocompatible for further examinations. In order to evaluate the scaffolds in vivo, rat animal models with critical size calvarial defects were randomly categorized in four groups and treated with the scaffolds. The animals were sacrificed at the time points of 4 and 12 weeks of post‐implantation, bone healing process were investigated. The histological and immunohistological observations showed (p < 0.01) higher osteogenesis capacity in the group treated with BM‐MSCs/scaffolds compared to the other groups. However, the formation of new angiogenesis was evidently higher in the defects filled with UC‐MSCs/scaffolds. This preliminary study provides promising data for further clinical trials. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 61–72, 2018.
Source: crossref · Quality: baseline

Research context

Ceramics & glassesNanomaterialsBiomaterials

OpenAlex topics: Bone Tissue Engineering Materials · Mesenchymal stem cell research · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran

National Cell Bank Pasteur Institute of Iran Tehran Iran

Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine Iran University of Medical Sciences Tehran Iran

Cellular and Molecular Research Center (CMRC) Iran University of Medical Sciences Tehran Iran

Diabetes Research Center Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences Tehran Iran

Department of Medical Genetics, School of Medicine Tehran University of Medical Sciences Tehran Iran

Department of Anatomy Faculty of Medicine, Iran University of Medical Sciences Tehran Iran

Cellular and Molecular Biology Research Centre Shahid Beheshti University of Medical Science Tehran Iran

Department of Molecular Medicine Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences Tehran Iran

Division of Surgery and Interventional Science UCL Centre for Nanotechnology and Regenerative Medicine, University College London London UK

References (42)

Show source-provided references
1. 10.1615/CritRevBiomedEng.v40.i5.1010.1615/CritRevBiomedEng.v40.i5.10 ↗
2. 10.1038/icb.2012.6410.1038/icb.2012.64 ↗
3. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges
4. 10.1016/j.actbio.2016.08.05310.1016/j.actbio.2016.08.053 ↗
5. 10.1080/00914037.2014.97789310.1080/00914037.2014.977893 ↗
6. 10.1371/journal.pmed.004000910.1371/journal.pmed.0040009 ↗
7. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
8. 10.1016/j.tice.2013.05.00210.1016/j.tice.2013.05.002 ↗
9. 10.1007/10_2011_10610.1007/10_2011_106 ↗
10. 10.1055/s-0029-122477710.1055/s-0029-1224777 ↗
11. 10.1002/jbm.a.3571010.1002/jbm.a.35710 ↗
12. 10.1002/jbm.a.3573110.1002/jbm.a.35731 ↗
13. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
14. 10.1002/jbm.82023070310.1002/jbm.820230703 ↗
15. 10.1016/j.actbio.2012.08.02310.1016/j.actbio.2012.08.023 ↗
16. 10.1016/j.actbio.2011.03.01610.1016/j.actbio.2011.03.016 ↗
17. 10.1016/j.jnoncrysol.2016.07.02510.1016/j.jnoncrysol.2016.07.025 ↗
18. 10.1007/s10856-006-0435-910.1007/s10856-006-0435-9 ↗
19. Novel porous gelatin scaffolds by overrun/particle leaching process for tissue engineering applications10.1002/jbm.b.30553 ↗
20. 10.1155/2016/618048710.1155/2016/6180487 ↗
21. 10.1186/scrt1010.1186/scrt10 ↗
22. 10.1016/j.biocel.2003.11.00110.1016/j.biocel.2003.11.001 ↗
23. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers
24. 10.1186/s13287-015-0066-510.1186/s13287-015-0066-5 ↗
25. 10.4161/org.604810.4161/org.6048 ↗
26. 10.1002/jbm.a.3218610.1002/jbm.a.32186 ↗
27. 10.3390/ijms14061169210.3390/ijms140611692 ↗
28. 10.4252/wjsc.v6.i2.14410.4252/wjsc.v6.i2.144 ↗
29. 10.1016/j.ymeth.2008.03.00610.1016/j.ymeth.2008.03.006 ↗
30. 10.1091/mbc.e02-02-010510.1091/mbc.e02-02-0105 ↗
31. 10.1016/j.ceramint.2010.07.01010.1016/j.ceramint.2010.07.010 ↗
32. 10.1155/2014/89893010.1155/2014/898930 ↗
33. 10.1016/j.apsusc.2010.09.00810.1016/j.apsusc.2010.09.008 ↗
34. A porous hydroxyapatite/gelatin nanocomposite scaffold for bone tissue repair: In vitro and in vivo evaluation10.1163/156856211X617713 ↗
35. 10.3390/ijms14061169210.3390/ijms140611692 ↗
36. Isolation and expansion of mesenchymal stem cells/multipotential stromal cells from human bone marrow10.1007/978-1-60761-999-4_2 ↗
37. 10.1089/scd.2014.049010.1089/scd.2014.0490 ↗
38. 10.1155/2012/97587110.1155/2012/975871 ↗
39. 10.1038/nprot.2012.11310.1038/nprot.2012.113 ↗
40. 10.1089/ten.tea.2012.035710.1089/ten.tea.2012.0357 ↗
41. 10.1002/term.9010.1002/term.90 ↗
42. 10.1166/jnn.2014.912710.1166/jnn.2014.9127 ↗